CLL | Tumor

CLL Patient Advocate Helped Many

May 13th 2019

Christopher Harington Dwyer, founder of CLL Canada and online chat contributor, leaves a legacy of support and knowledge.

Calquence Significantly Improves Survival in Patients with Chronic Lymphocytic Leukemia

May 7th 2019

The Bruton tyrosine kinase inhibitor showed a statistically-significant and clinically-meaningful improvement in progression-free survival in patients with previously-treated CLL.

Cancer Survivorship and the Mysterious 'New Normal'

May 3rd 2019

Most people have heard the term "new normal" for individuals living, surviving and struggling with cancer. What actually does that mean?

Risk for Disease Progression Changes Over Time in CLL, Depending on Somatic Mutations

April 30th 2019

Risk for disease progression among patients with chronic lymphocytic leukemia over time differed between those with mutated or unmutated disease, showing that gene somatic hypermutation plays a role throughout the disease course.

Novel Agents Show Promise in Chronic Lymphocytic Leukemia

April 4th 2019

An expert discusses new treatment options for patients diagnosed with CLL.

Changing Treatment Options Offer Next Advances in Chronic Lymphocytic Leukemia

April 3rd 2019

Patients with relapsed or refractory chronic lymphocytic leukemia may have more options now than ever before, according to William G. Wierda, M.D., Ph.D.

Front-line Combinations with New Agents Evolve Chronic Lymphocytic Leukemia Landscape

April 2nd 2019

While novel agents continue to evolve in the treatment landscape for chronic lymphocytic leukemia, many may start to be combined in the front-line setting as well, according to Matthew S. Davids, M.D., MMSc.

Shorter Treatment with Venclexta May Save Costs for Some With CLL

March 8th 2019

Time-limited treatment could be the new wave of research in the treatment of chronic lymphocytic leukemia (CLL), according to Nicole Lamanna, M.D.

CURE's Top 5 Stories: February 2019

March 1st 2019

Here are the top 5 CURE stories for February 2019.

Diagnosis

February 20th 2019

A CLL diagnosis comes with new challenges, from understanding signs and symptoms and what the different stages mean.

Survivorship Planning

February 20th 2019

Understanding CLL as a chronic disease.

Before Treatment

February 20th 2019

Knowing treatment options and the possibilities of supportive care.

During Treatment

February 20th 2019

Utilizing clinical trials and understanding potential side effects and complications.

After Treatment

February 20th 2019

Finding follow-up care and emotional support.

Caregiving

February 20th 2019

Serving as a caregiver for a loved one going through a CLL diagnosis and treatment while utilizing resources to take care of oneself.

Important Resources

February 20th 2019

A list of helpful resources to assist people with CLL and their families cope with the emotional and practical aspects of the disease.

Imbruvica May Be Superior to Standard of Care in Elderly Patients with CLL

February 11th 2019

Imbruvica (ibrutinib) may be superior to standard of care in elderly patients with untreated chronic lymphocytic leukemia (CLL), according to phase 3 findings published in the New England Journal of Medicine.

Expert Discusses Copiktra for Relapsed/Refractory CLL

February 6th 2019

Ian W. Flinn, M.D., Ph.D., discusses the use of Copiktra, which was approved in September for patients with relapsed/refractory chronic lymphocytic leukemia.

FDA Approves First Non-Chemotherapy Combo for Treatment-naive CLL

January 28th 2019

The Food and Drug Administration approved Imbruvica plus Gazyva for treatment-naïve patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

Two Doctors on a Similar Path to Help Those with CLL

January 24th 2019

In this week’s episode of CURE Talks Cancer, we spoke with two doctors honored for their efforts to improve the quality of life for those affected by chronic lymphocytic leukemia (CLL).

Cure: Is it Possible for CLL?

January 10th 2019

Will the word "cure" be used for patients with chronic lymphocytic leukemia (CLL)?

Physician Turns Personal Diagnosis to Educational Opportunity

January 5th 2019

Brian Koffman is a family physician who used his own CLL diagnosis to start a group that informs other patients and their loved ones.

Navigating Through CLL Treatment

December 27th 2018

CLL Management: Establishing a Network of Support

December 27th 2018

Managing Side Events From Targeted Therapy for CLL

December 27th 2018

Danise: Experience With Venetoclax Targeted Therapy

December 27th 2018

Considering a Clinical Trial for CLL Treatment

December 27th 2018

Clinical Trial Participation in CLL

December 27th 2018

Chemoimmunotherapy in CLL

December 27th 2018

Tests Used to Inform Treatment Decisions in CLL

December 27th 2018